The GLP1 drugs are set to be the star performers for insulin drugmakers across the globe as the menace of diabetes and obesity is in line to rise exponentially in the years to come. GLP1 drugs or Glucagon-like peptide-1 agonists are medications which have traditionally been used to treat type…Read More
Novo Nordisks Obesity Drug Pipeline Stacked Up For Next 1520 Yrs Says GBS MD John C Dawber
